Universita degli Studi di Roma la Sapienza

• Lorenzo Maria DONINI

  Lead investigator

Sources: openalex.org

• European Commission

  HORIZON-TMA-MSCA-SE, European staff EXchange Programme fOr deSigning pErSonalised prevention of future healthcare, 101299724, €185.4k, 2026–2030, 4 Jun 2026

• Agence Nationale de la Recherche

  THCS, Sarcopenic Obesity prevention by Nutrition, Exercise and Technology To prevent Overreliance on secondary care, ANR-25-THCS-0002, €268.9k, 2026, 1 Apr 2026

• European Research Council

  ERC-STG, Bioprinting with Real-time Imaging and cell-biomaterial Density for Growth Enhancement, 101221358, €2m, 2026–2031, 13 Feb 2026

• European Commission

  HORIZON-RIA, Devising a personalized risk stratification and holistic management for prevention of cognitive impairment in patients with different cardiovascular phenotypes, 101156266, €158.6k, 2025–2029, 2 Dec 2024

• European Commission

  HORIZON-RIA, Validation of α-synuclein Modifications in Parkinson’s dIsoRder Evolution, 101156370, €202.6k, 2024–2029, 5 Nov 2024

• European Commission

  HORIZON-RIA, AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients, 101136299, €151.7k, 2024–2027, 7 Dec 2023

Sources: cordis.europa.eu, openalex.org

• Modulation of circulating osteocalcin-expressing monocytes by glucagon like peptide-1 receptor agonists in type 2 diabetes: an exploratory pilot study

  21 Sept 2026

• Unsupervised machine learning with Cluster Analysis in patients with rheumatoid arthritis: insights in CV risk phenotypes from a multicentre Italian cohort

  2 Sept 2026

Sources: api.crossref.org